The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| פורמט: | Revisão |
| שפה: | אנגלית |
| יצא לאור: |
2020
|
| גישה מקוונת: | https://doi.org/10.3389/fimmu.2020.00888 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|